Trials / Completed
CompletedNCT03569579
CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Effect of D797 on Pharmacokinetics of D324 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction between D797 of D324 in healthy volunteers
Detailed description
To healthy subjects of twenty(20), following treatments are administered dosing in each period and wash-out period is a minimum of 21 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Memantine Tab. 10mg | Memantine Tab. 10mg\* 2T/day, QD, PO |
| DRUG | Memantine Tab. 10mg + Donepezil Tab. 10mg | Memantine Tab. 10mg\* 2T/day + Donepezil Tab. 10mg \* 1T/day, QD, PO |
Timeline
- Start date
- 2018-04-16
- Primary completion
- 2018-05-21
- Completion
- 2018-06-04
- First posted
- 2018-06-26
- Last updated
- 2018-06-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03569579. Inclusion in this directory is not an endorsement.